FDA uncovers data manipulation at Immunomedics plant making cancer drug

13th February 2019 Uncategorised 0

The FDA has released a Form 483 from the inspection of the Immunomedics plant showing big issues with data integrity at the Morris Plains, New Jersey, plant where sacituzumab govitecan is being made.

More: FDA uncovers data manipulation at Immunomedics plant making cancer drug
Source: fierce